4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-022547
President and CEO sold 47,172 shares at an average $3.53 ($166,702)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AUERBACH ALAN H President and CEO | 2025-07-08 | Sale 10b5-1 | −25,592 | $3.53 | $90,417 | 7,202,481 | D |
| AUERBACH ALAN H President and CEO | 2025-07-09 | Sale 10b5-1 | −21,580 | $3.54 | $76,285 | 7,180,901 | D |
| Open-market sales · 47,172 sh · avg $3.53 · $166,702 | |||||||
Loading xslF345X05/rdgdoc.xml…